From Galway to San Diego: ONK Therapeutics’ Aim to Usher in A New Era of Engineered NK Cell Therapies with the Goal to Ultimately Cure Cancer

JLabs – View full story

ONK inks deal for novel NK cell technology

The PharmaLetter – View full story

Maximizing synergy and mitigating resistance: novel dual-targeted natural killer cell therapies for cancer

Nature BioPharma Dealmaker – View full story